Your browser doesn't support javascript.
loading
The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.
Chow, Ronald; Im, James; Chiu, Nicholas; Chiu, Leonard; Aggarwal, Rahul; Lee, Jihui; Choi, Young-Geun; Prsic, Elizabeth Horn; Shin, Hyun Joon.
Afiliação
  • Chow R; Yale School of Public Health, Yale University, New Haven, Connecticut, United States of America.
  • Im J; Yale New Haven Health, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America.
  • Chiu N; Hanyang Impact Science Research Center, Seoul, Korea.
  • Chiu L; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Aggarwal R; Beth Israel Deaconess Medical Center, Harvard Medical School, Harvard University, Boston, Massachusetts, United States of America.
  • Lee J; Columbia University Vagelos College of Physicians and Surgeons, Columbia University, New York City, New York, United States of America.
  • Choi YG; Beth Israel Deaconess Medical Center, Harvard Medical School, Harvard University, Boston, Massachusetts, United States of America.
  • Prsic EH; Weill Cornell Medicine, New York, New York, United States of America.
  • Shin HJ; Sookmyung Women's University, Seoul, Korea.
PLoS One ; 16(6): e0253576, 2021.
Article em En | MEDLINE | ID: mdl-34166458

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Síndrome da Liberação de Citocina / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: PLoS One Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Síndrome da Liberação de Citocina / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: PLoS One Ano de publicação: 2021 Tipo de documento: Article